课题基金 / 基金详情

Novel therapies to treat muscle wasting in cancer

Novel therapies to treat muscle wasting in cancer
治疗癌症肌肉萎缩的新疗法
批准号:
nhmrc : 1041865
负责人:
Dr Kate Murphy
金额:
$39.3万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-01-01 至 2016-12-31

项目摘要

项目成果

Dr Kate Murphy的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cancer cachexia is a devastating disease characterised by muscle wasting, weakness and fatigue. It impairs patient quality of life and accounts for >20% of cancer-related deaths. This project will identify factors responsible for cancer cachexia and develop new strategies to alleviate wasting and weakness in cancer patients, to improve their quality of life and reduce mortality.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Treating muscle wasting in cancer
  • 批准号:
    nhmrc : GNT1023178
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $39.11万
  • 财政年份:
    2012
  • 负责人:
    Dr Kate Murphy
  • 依托单位:
Inhibiting the Renin-Angiotensin System to treat wasting in cancer
  • 批准号:
    nhmrc : 1023178
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $30.2万
  • 财政年份:
    2012
  • 负责人:
    Dr Kate Murphy
  • 依托单位:
Effects of parvalbumin up-regulation on Ca2+ handling and contractile properties in skeletal muscle from aged mice
  • 批准号:
    nhmrc : 520186
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $19.16万
  • 财政年份:
    2008
  • 负责人:
    Dr Kate Murphy
  • 依托单位:
国内基金
海外基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data